Scott Morrison

India’s pharmaceutical industry is growing at a tremendous rate, and among them the most lucrative one is the cardiac diabetic pharma franchise sector . Due to the increase in the number of lifestyle disorders like diabetes, hypertension, and cardiac diseases, the demand for specialised drugs is also increasing. This provides a golden opportunity for entrepreneurs, medical representatives, distributors, and healthcare professionals who are looking to establish a successful pharmaceutical venture . Growing Demand for Cardiac and Diabetic Medicines India has earned the nickname ‘diabetes capital of the world’, as there are millions of people who need drugs on a constant basis for their treatment. Likewise, cardiovascular diseases have remained the main reasons for deaths in India. It is because of this reason that healthcare facilities are always looking out for trustworthy pharmaceutical firms that can provide heart and diabetes drugs. The increasing number of patients in such categorie...

The Cardio-Diabetic and Chronic Health Disorders keep moving into the new paradigm. One of the world’s most serious Chronic Health Disorders, Cardio-diabetic is on its new journey as the Pharmaceutical Industry comes into the light by delivering the next-generation solutions and medicines and it is all going to change for good to transform the lives of patients, managing their Chronic Health Disorders. Medical practitioners are seeing and embracing a completely different kind of Cardiac and Diabetic Pharmaceutical Solution which goes all out to take proper care of these inter-connected Chronic Health Disorders. Today’s most advanced diabetic medicines, DPP-4 inhibitors and SGLT2 inhibitors have proven themselves not just for managing blood glucose but for managing the very core of your heart as well – your life will change in a big way with the availability of these. These not just control and maintain blood sugar but do so by helping you avoid and lower your risk of experiencing heart...

There is a substantial transformation occurring in the Indian Pharmaceutical market which has two therapy segments as a stronger growth engine-Cardiac and anti-diabetic medicines. Driven by rapid changes in disease burden, urbanization and lifestyle, demand for these drugs will never fall flat. The Scale of the Problem The figures are astonishing, cardiovascular diseases cause 28% of all deaths in India as reported by WHO whereas more than 80 million Indians are currently suffering from diabetes and it is estimated to be more than 98 million in 2025. INDIAB report by the Indian Council of Medical Research claims there are 101 million Indians suffering from diabetes and the risk factors are urbanisation, age, obesity, poor diet and genetic factor.  The dual epidemics lead to persistent growing demand in both the therapy segments. The TribuneInternational Journal of Pharmaceutical Sciences Market Size and Growth Trajectory The figures indicate robust commercial demand. India's diabet...

Cardiac and diabetic drugs are not purchases that are made from time to time, but in fact become an integral part of a patients routine and often last lifetime. This one simple factor changes the entire dynamics of how such products reach a patient.  A missed refill appointment in this case may not just mean a lost opportunity but an emergency situation. The network for such products therefore needs more rigor, reach, reliability than probably any other pharmaceutical segment. Start with Therapy-Specific Demand Mapping Cardiovascular and diabetes patients’ densities differ widely across geographic regions, demographics, lifestyle factors. Before appointing C&F agents or distributors for new territories, map out existing prescriptions, footfall of hospitals in the area, and incidence rates of chronic diseases. This will ensure that the inventory is stocked where sustained demand actually exists, rather than thinly distributed across markets that have low sustained need. Choose D...

There has been impressive growth in the pharmaceutical sector of India, particularly within specific sectors like cardiac and diabetic treatments. Due to an increase in heart-related diseases, high blood pressure, and diabetes, the need for good quality drugs increases. This has led to an influx of individuals into the Cardiac Diabetic PCD Franchise business . But for one to be successful in this highly competitive industry, marketing has to be incorporated in the business. There is a role of marketing support in assisting the franchise partners in establishing themselves and building up their reputation among healthcare practitioners and other customers. When there is enough marketing help available from a firm, it enables its franchises to concentrate on business development. Why Marketing Support Matters in a Cardiac Diabetic PCD Franchise? The cardiac and diabetes niche requires high specialisation in trust, product knowledge, and interaction with doctors, chemists, and health pra...

A rise in lifestyle diseases in the country like diabetes and cardiac disorders has made the demand for quality healthcare and life-saving drugs greater than ever before. Specialized cardiac diabetic pharma companies cater to the expanding healthcare needs of patients across India with the help of their innovative medicines for prevention and treatment of various serious health conditions.  These companies are primarily involved in manufacturing a vast range of products aimed at helping the health condition, treating and preventing various critical problems faced by human beings across various age groups, and even long term managing of diseases with medications and remedies. Anti-diabetic medicines: One of the major categories of products made available by the leading cardiac diabetic pharmaceutical firms includes anti-diabetic medications. These medications regulate the level of blood glucose, improving insulin levels and sensitivity in people suffering from diabetes.  There ...

The Indian pharmaceutical industry is experiencing an unprecedented surge. Among the various therapeutic segments available to pharma entrepreneurs, Cardiac and Diabetic PCD franchises have become the most rewarding and lucrative segments to enter. But while deciding to invest in a Cardiac Diabetic PCD pharma franchise, a question looms, "Which segment is better for business growth, Cardiac or Diabetic?" In this blog, we will analyze each segment and help you make an informed decision about your next venture. Understanding the Market Landscape In India, over 77 million patients suffer from diabetes and cardiovascular diseases (CVDs) are responsible for about 28 percent of deaths in the country, thereby highlighting the immense need for cardiac treatments. These are chronic diseases and require patients to take medications continuously. This consistent need for drugs, in both these segments, is a major plus for PCD franchise owners. Cardiac PCD Segment: Strengths and growth dr...